Cannabis Stocks Technical Analysis provided on Strain Insider is for information purposes only. Signals that are given in this article are solely based on probabilities. Every trading and investment move involves risk, you should conduct your own research when making a decision. Strain Insider and its authors are not accountable for any trading decisions you make.

Cannabis stocks have proven to be a highly promising investment and trading vehicle during 2018. With stock prices that increased by up to four-digit percentages and the improvements of medical and recreational cannabis legislation around the globe, the legal marijuana industry can be considered as one of the most promising in the world. In this weekly technical analysis series, Strain Insider aims to provide an outlook on five of the most relevant cannabis stocks.

Related: Cannabis Stocks Technical Analysis – November 2018

This week’s piece features Aurora Cannabis Inc., GW Pharmaceuticals Plc., Tilray Inc., Cronos Group Inc. and Canopy Growth Corporation.

Major news this week:

Tilray: Cannabis producer Tilray misses on both sales and earnings

Aurora Cannabis: Aurora Cannabis soon to supply Mexico with medical marijuana

Canopy Growth: Canopy Growth acquires Volcano Vaporizer inventor Storz & Bickel

Cronos Group: Marlboro creator buys 45% of Cronos Group in a $2.4 billion mega-deal

GW Pharmaceuticals: GW Pharmaceuticals Announces Second Positive Phase 3 for new CBD drug

Related: Cannabis Industry Weekly Roundup – December 8